MALAKOFF, France–(BUSINESS WIRE)–Regulatory News: Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription Commitments Totalling €4.5 Million This press release and the information it contains must not be distributed, directly or indirectly, in the United States, Canada, Japan or Australia. Theraclion (ISIN: